about
trans-Chlorido-(4-fluoro-benzene-thiol-ato-κS)bis-(tri-phenyl-phosphane-κP)palladium(II) methanol hemisolvate.Bis(2,3-di-chloro-phen-yl) di-sulfide.Bis(methyl xanthato)-κS;κS:S'-(triphenyl-phosphane-κP)palladium(II)Di-chlorido-(4,4'-di-tert-butyl-2,2'-bi-pyridine-κ(2) N,N')palladium(II) dimethyl sulfoxide monosolvate monohydrate.N-{1,2-Bis(pyridin-3-yl)-2-[(E)-(pyridin-3-yl)methyl-idene-amino]-eth-yl}nicotinamide.4-Methyl-N-(4-methyl-phenyl-sulfon-yl)-N-[4-(4-methyl-phen-yl)-1,3-thia-zol-2-yl]benzene-sulfonamide.N-Benzyl-2-hy-droxy-ethanaminium cyanurate.Crystal structure of 1-meth-oxy-pyrene.Two coordination modes of Cu(II) in a binuclear complex with N-(pyridin-2-yl-carbon-yl)pyridine-2-carboxamidate ligands.cis-Bis(O-methyl-dithio-carbonato-κ(2) S,S')bis-(tri-phenyl-phosphane-κP)ruthenium(II).Crystal structure of 2-(thio-phen-3-yl)ethyl pyrene-1-carboxyl-ate.Bis(2-amino-4-phenyl-1,3-thia-zol-3-ium) tetra-chlorido-palladate(II).trans-Bis(5-amino-1,3,4-thia-diazol-2-thio-lato-κS(2))bis-(triphenyl-phosphane-κP)palladium(II) dimethyl sulfoxide disolvate hemihydrate.3-[(R)-1-Hy-droxy-butan-2-yl]-1,2,3-benzo-triazin-4(3H)-one.trans-Bis(μ-benzene-thiol-ato-κ(2) S:S)bis[chlorido-(tri-phenyl-phosphane-κP)palladium(II)] chloro-form disolvate24- and 26-membered macrocyclic diorganotin(IV) bis-dithiocarbamate complexes with N,N'-disubstituted 1,3- and 1,4-bis(aminomethyl)benzene and 1,1'-bis(aminomethyl)ferrocene as spacer groups.Theoretical study of the experimental coordination behavior of N-(2-aminophenyl)-D-glycero-D-gulo-heptonamide to Hg(II) ion.A comparative study of the packing of two polymorphs of the nickel(II) pincer complex [2,6-bis(di-tert-butylphosphinoyl)-4-(3,5-dinitrobenzoyloxy)phenyl-κ(3)P,C(1),P']chloridonickel(II).Exoconformers ofN-(pyridin-2-yl)- andN-(pyridin-3-yl)norbornene-5,6-dicarboximide crystalsCrystal structure and NMR spectroscopy of aldonamides derived from D-glycero-D-gulo-heptono-1,4-lactoneSelf-assembly of diphenyltin(IV) and tris-dithiocarbamate ligands to racemic trinuclear cavitands and capsulesSulfonate salts of the therapeutic agent dapsone: 4-[(4-aminophenyl)sulfonyl]anilinium benzenesulfonate monohydrate and 4-[(4-aminophenyl)sulfonyl]anilinium methanesulfonate monohydrate
P50
Q38946892-8617CDCF-00C5-4C37-B572-9FB43C874707Q39271101-1F26A601-DBF8-4817-8C6E-9AF046E5215DQ40013587-C9BD5EB7-7BE7-470C-9CE9-E9BF1EF910ACQ40496616-14D5FEFB-993F-4F51-8528-FB1799F95095Q40519088-63DEB669-1D1E-47FA-8A32-9183C4AD4A33Q41841295-ABDFC6AC-C82C-4B7D-9EF0-F676C449BB73Q41859213-E0044566-BF00-40CD-9FF8-D447BC35E9CCQ41932857-D1A46241-63B5-4AC5-8C68-4BFA021041EFQ41975755-E3517FC8-551F-4F65-A3A6-D18D9A8E1EA8Q41989675-2E97F575-F5FA-4EF1-8222-56D0E3161E57Q41993341-1CB7050E-7ADD-4434-9276-72375CF56329Q42060894-10578A05-EDF9-4D54-9A32-83B37A62772BQ42147085-350ABC33-34A5-4296-9AA4-6C38A81B7D3FQ42390679-DA7689EE-2F17-42F4-ACC8-EEDB10B9AC55Q42658009-F52BBF69-0145-4DE3-B41C-98E6EDF40EB9Q46339271-4CE08B2E-4CB7-42A3-A7F9-8D33FC1BA523Q46386783-66E9E12A-1D99-4F5C-823F-85A2DAD05FD3Q53110155-102B91A4-30CB-496C-920C-E8EDC681A745Q57663331-AE7128FE-4193-4C46-99E5-A5A6098F2DB2Q79437577-90BC5310-70B9-4F59-8DDB-42A944611D3BQ82711159-BFE57D6B-5F68-4AE2-B9EC-1BC402937342Q89121531-8D96B8AF-CD3E-47D7-B9E6-EF4A1C30C135
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Reyna Reyes-Martínez
@ast
Reyna Reyes-Martínez
@en
Reyna Reyes-Martínez
@es
Reyna Reyes-Martínez
@nl
type
label
Reyna Reyes-Martínez
@ast
Reyna Reyes-Martínez
@en
Reyna Reyes-Martínez
@es
Reyna Reyes-Martínez
@nl
prefLabel
Reyna Reyes-Martínez
@ast
Reyna Reyes-Martínez
@en
Reyna Reyes-Martínez
@es
Reyna Reyes-Martínez
@nl
P106
P1153
56013644800
P21
P31
P496
0000-0003-0153-1180